BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioMidwest

  SomaLogic to Participate in the 41st Annual J.P. Morgan Healthcare Conference

  SomaLogic, Inc., a leader in proteomics technology, announced that the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference.

  December 29, 2022

   · 

  1 min read
• Business

  Neuronetics Announces Appointment of Joseph H. Capper to its Board of Directors

  Neuronetics, Inc. announced the appointment of Joseph H. Capper to its Board of Directors and as a member of the Audit Committee effective January 1, 2023.

  December 29, 2022

   · 

  4 min read
• Deals

  Sesen Bio and Carisma Therapeutics Announce Substantial Increase to Expected Special Cash Dividend in Connection with Pending Merger

  Sesen Bio, Inc. and Carisma Therapeutics Inc., a privately-held, clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced an amendment to their previously announced merger agreement dated September 20, 2022.

  December 29, 2022

   · 

  15 min read
• Business

  OTC Markets Group Grants Evofem Additional Time to File Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2022

  Evofem Biosciences, Inc. announced that it has been granted additional time by the OTC Markets Group to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2022.

  December 29, 2022

   · 

  1 min read
• Tiziana Life Sciences Ltd (“Tiziana” or “the Company”) - Updated Interim Results for the Six Months Ended 30 June 2022

  Tiziana Life Sciences Ltd, a biotechnology company enabling breakthrough CNS immunomodulation approaches to enhance the functionality of Treg-based therapies, announced its interim results for the six months ended 30 June 2022.

  December 29, 2022

   · 

  7 min read
• Deals

  Disc Medicine Announces Completion of Merger with Gemini Therapeutics

  Disc Medicine, Inc. announced that its previously-announced merger with Gemini Therapeutics, Inc. closed on December 29, 2022, following the approval of Gemini shareholders.

  December 29, 2022

   · 

  8 min read
• Kane Biotech Announces Loan Transaction

  Kane Biotech Inc. announces that it has reached an agreement to obtain loans in the aggregate amount of $2,000,000 from two lenders.

  December 29, 2022

   · 

  3 min read
• Everest Medicines Announces China NMPA Recommends Priority Review for Nefecon for the Treatment of Primary IgA Nephropathy

  Everest Medicines announced that the Center for Drug Evaluation of the China National Medical Products Administration has recommended Priority Review for the New Drug Application of Nefecon for the treatment of primary immunoglobulin A nephropathy in adults at risk of rapid disease progression.

  December 29, 2022

   · 

  4 min read
• Everest Medicines to Hold New Corporate Strategy Online Conference Calls

  Everest Medicines, a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced that the Company’s management will host conference calls to introduce its new corporate strategy.

  December 29, 2022

   · 

  3 min read
• MedMira Introduces VYRA TriDemic

  MedMira Inc. presents its latest addition to the VYRATM product line, the VYRATM TriDemic Antigen Rapid Test for the simultaneous detection of SARS-CoV-2, Flu A, Flu B and Respiratory Syncytial Virus.

  December 29, 2022

   · 

  3 min read